# Prospective Biomarkers of Bone Metabolism in Hemophilia A

> **NCT02306694** · PHASE3 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 16 (actual)

## Conditions studied

- Hemophilia
- Bone Disease

## Interventions

- **DRUG:** Advate

## Key facts

- **NCT ID:** NCT02306694
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-04-16
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306694, "Prospective Biomarkers of Bone Metabolism in Hemophilia A". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02306694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*